Predicting short-term mortality in patients with pulmonary embolism: A simple model

American Journal of the Medical Sciences

Volumn 345, Issue 6, 2013, Pages 462-469

  Papaioannou, Andriana I ^a   Kastanis, Alcibiades ^a   Malli, Foteini ^a   Zakynthinos, Epameinontas ^a   Minas, Markos ^a   Mpakarozi, Mariana ^a   Moka, Stamatina ^a   Zintzaras, Elias ^a,b   Gourgoulianis, Konstantinos I ^a   Daniil, Zoe ^a  

^a UNIVERSITY OF THESSALY   (Greece)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Comorbidities; Congestive heart failure; Diabetes mellitus; Pulmonary embolism; Survival

Indexed keywords

ADULT; AGE; AGED; AREA UNDER THE CURVE; BLOOD CARBON DIOXIDE TENSION; BLOOD OXYGEN TENSION; CEREBROVASCULAR DISEASE; CHARLSON COMORBIDITY INDEX; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; DEATH; DEMENTIA; DIABETES MELLITUS; FEMALE; GENDER; HEART INFARCTION; HUMAN; LIVER DISEASE; LUNG ANGIOGRAPHY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; PERIPHERAL VASCULAR DISEASE; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SMOKING HABIT; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; SURVIVAL; TACHYCARDIA; TACHYPNEA;

EID: 84878450527     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e31826ca241     Document Type: Conference Paper

References (34)

1. Cohen AT, Agnelli G, Anderson FA, et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 2007;98:756-64.
2. Kurkciyan I, Meron G, Sterz F, et al. Pulmonary embolism as a cause of cardiac arrest: presentation and outcome. Arch Intern Med 2000;160: 1529-35.
3. Simonneau G, Sors H, Charbonnier B, et al. A comparison of lowmolecular- weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: evaluations dans l'Embolie Pulmonaire. N Engl J Med 1997; 337:663-9.
4. Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008;29: 2276-315.
5. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999;353:1386-9.
6. Aujesky D, Obrosky DS, Stone RA, et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 2005;172:1041-6.
7. Aujesky D, Perrier A, Roy PM, et al. Validation of a clinical prognostic model to identify low-risk patients with pulmonary embolism. J Intern Med 2007;261:597-604.
8. Jimenez D, Aujesky D, Moores L, et al. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med 2010;170:1383-9.
9. Wicki J, Perrier A, Perneger TV, et al. Predicting adverse outcome in patients with acute pulmonary embolism: a risk score. Thromb Haemost 2000;84:548-52.
10. Jimenez D, Yusen RD, Otero R, et al. Prognostic models for selecting patients with acute pulmonary embolism for initial outpatient therapy. Chest 2007;132:24-30.
11. Fedullo PF, Tapson VF. Clinical practice. The evaluation of suspected pulmonary embolism. N Engl J Med 2003;349:1247-56.
12. Grifoni S, Olivotto I, Cecchini P, et al. Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. Circulation 2000;101:2817-22.
13. Keane MP, Strieter RM, Belperio JA. (20060 9Macrophage Inflammatory Proteins (CCL3, CCL4, CCL9/10, CCL15, CCL18, CCL19, CCL20, CXCL2)9 In: Laurent GJ, and Shapiro SD (eds). Encyclopedia of Respiratory Medicine. Oxford: Elsevier Limited.
14. Hall WH, Ramachandran R, Narayan S, et al. An electronic application for rapidly calculating Charlson comorbidity score. BMC Cancer 2004;4:94.
15. British Thoracic Society guidelines for the management of suspected acute pulmonary embolism. Thorax 2003;58:470-84.
16. Zintzaras E, Bai M, Douligeris C, et al. A tree-based decision rule for identifying profile groups of cases without predefined classes: application in diffuse large B-cell lymphomas. Comput Biol Med 2007;37:637-41.
17. Zintzaras E, Kowald A. Forest classification trees and forest support vector machines algorithms: demonstration using microarray data. Comput Biol Med 2010;40:519-24.
18. Wells PS, Anderson DR, Rodger MA, et al. A randomized trial comparing 2 low-molecular-weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolism. Arch Intern Med 2005;165:733-8.
19. Lim AY, Parr DG, Stableforth DE, et al. Early discharge and home supervision of patients with pulmonary embolism treated with lowmolecular weight heparin. Eur J Intern Med 2003;14:89-93.
20. Beer JH, Burger M, Gretener S, et al. Outpatient treatment of pulmonary embolism is feasible and safe in a substantial proportion of patients. J Thromb Haemost 2003;1:186-7.
21. Nendaz MR, Bandelier P, Aujesky D, et al. Validation of a risk score identifying patients with acute pulmonary embolism, who are at low risk of clinical adverse outcome. Thromb Haemost 2004;91:1232-6.
22. Green RM, Meyer TJ, Dunn M, et al. Pulmonary embolism in younger adults. Chest 1992;101:1507-11.
23. Stein PD, Goldhaber SZ, Henry JW. Alveolar-arterial oxygen gradient in the assessment of acute pulmonary embolism. Chest 1995;107:139-43.
24. Bednarek M, Maciejewski J, Wozniak M, et al. Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax 2008; 63:402-7.
25. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
26. Cannon CP. Cardiovascular disease and modifiable cardiometabolic risk factors. Clin Cornerstone 2007;8:11-28.
27. Gangireddy C, Rectenwald JR, Upchurch GR, et al. Risk factors and clinical impact of postoperative symptomatic venous thromboembolism. J Vasc Surg 2007;45:335-41; discussion 341-2.
28. ten Wolde M, Sohne M, Quak E, et al. Prognostic value of echocardiographically assessed right ventricular dysfunction in patients with pulmonary embolism. Arch Intern Med 2004;164:1685-9.
29. Gibson NS, Sohne M, Buller HR. Prognostic value of echocardiography and spiral computed tomography in patients with pulmonary embolism. Curr Opin Pulm Med 2005;11:380-4.
30. Jimenez D, Yusen RD. Prognostic models for selecting patients with acute pulmonary embolism for initial outpatient therapy. Curr Opin Pulm Med 2008;14:414-21.
31. Silverstein MD, Heit JA, Mohr DN, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year populationbased study. Arch Intern Med 1998;158:585-93.
32. Kasper W, Konstantinides S, Geibel A, et al. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol 1997;30: 1165-71.
33. Lankeit M, Konstantinides S. Is it time for home treatment of pulmonary embolism? Eur Respir J. 2012;40:742-49.
34. Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133:454S-545S.